Biotech · Private company · Chapel Hill, NC, US
BioKier Inc.
Track this companyFree. Adds BioKier Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BKR-017HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- BKR-017Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Pharmacokinetics of Butyrate Tablet BKR-017COMPLETED · started Jul 16, 2025ClinicalTrials.gov NCT06556745 · fetched Nov 12, 2026
- Butyrate Adjuvant Therapy for Type 1 DiabetesPHASE1_PHASE2 · COMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT03999853 · fetched Nov 12, 2026
- Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes PatientsNA · COMPLETED · started Apr 18, 2021ClinicalTrials.gov NCT04673656 · fetched Nov 12, 2026
- Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes PatientsNA · COMPLETED · started Jun 16, 2020ClinicalTrials.gov NCT04279444 · fetched Nov 12, 2026
NIH awards1
- Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular diseaseFiscal year 2024 · $435.9KNIH RePORTER 1R43HL174321-01A1 · fetched Nov 12, 2026